ProZinc

RSS

insulin human

Authorised
This medicine is authorised for use in the European Union.

Overview

This is a summary of the European public assessment report. Its purpose is to explain how the assessment done by the Committee for Medicinal Products for Veterinary Use (CVMP) on the basis of the documentation provided, led to the recommendations on the conditions of use.

This summary cannot replace a face-to-face discussion with your veterinarian. If you need more information about your animal’s medical condition or treatment, contact your veterinarian. If you want more information on the basis of the CVMP recommendations, read the scientific discussion (also part of the EPAR).

This EPAR was last updated on 25/04/2018

Authorisation details

Product details
Name
ProZinc
Agency product number
EMEA/V/C/002634
Active substance
insulin human
International non-proprietary name (INN) or common name
insulin human
Species
Cats
Anatomical therapeutic chemical veterinary (ATCvet) codes
QA10AC01
Publication details
Marketing-authorisation holder
Boehringer Ingelheim Vetmedica GmbH
Revision
7
Date of issue of marketing authorisation valid throughout the European Union
12/07/2013
Contact address
Binger Strasse 73
55216 Ingelheim/Rhein
Germany

Product information

13/04/2018 ProZinc - EMEA/V/C/002634 - R/0013

Contents

  • Annex I - Summary of product characteristics
  • Annex IIA - Manufacturing-authorisation holder responsible for batch release
  • Annex IIB - Conditions of the marketing authorisation
  • Annex IIIA - Labelling
  • Annex IIIB - Package leaflet

Please note that the size of the above document can exceed 50 pages.

You are therefore advised to be selective about which sections or pages you wish to print.

Pharmacotherapeutic group

  • Insulins and analogues for injection
  • intermediate acting Insulin (human)

Therapeutic indication

For the treatment of diabetes mellitus in cats to achieve reduction of hyperglycaemia and improvement of associated clinical signs

Assessment history

How useful was this page?

Add your rating